Reassessing the effects of continuous positive airway pressure (CPAP) on arterial stiffness and peripheral blood derived CD34+ progenitor cells in subjects with sleep apnea
Open Access
- 21 May 2019
- journal article
- research article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 10 (1) , 1-7
Abstract
Obstructive sleep apnea (OSA) is an independent risk factor for cardiovascular diseases (CVD) and vascular health. Peripheral blood-derived CD34+ progenitor cells have been used as biomarker for CVD risk and may play a similar role in OSA and CVD risk assessment. Although there are some controversial results in the literature, OSA patients may have a reduction in the number and function of CD34+ cells. The damages promoted by OSA in CD34+ cells may lead to an increase in endothelial oxidative stress and endothelial inflammation which may lead to a reduced endothelial repair capacity. In this study, we explored the effect of continuous positive airway pressure (CPAP) on peripheral blood-derived CD34+ cells and arterial stiffness (another predictor of endothelial health and CVD risk) in OSA patients. Nine overweight and obese subjects without prediabetes or diabetes were recruited. Eight out of nine subjects had moderate to severe degree of OSA. CD34+ cells were isolated from peripheral blood. Number and function of these cells were monitored before and after 3 months of treatment with CPAP. No significant changes were observed in the number of CD34+ cells, CFU-Hill’s colony formation unit (CFU) count or migratory response to the chemotactic factor SDF-1a after CPAP use. However, CXCR4 mRNA expression significantly increased by 2.2-fold indicating that CPAP may have a positive effect on SDF1a receptor (CXCR4), thereby improving migration of CD34+ cells mediated by SDF1a after the 3 month period. Interestingly, in clinical arena our results showed a reduction of pulse wave velocity (an established parameter of arterial stiffness) following CPAP therapy. Our findings suggest that 3-month CPAP intervention does not show statistical significant increase in CD34+ cell number and function, in mostly moderate to severe OSA subjects; however, it did demonstrate a positive trend. CPAP therapy, did help improve arterial stiffness parameter.Keywords
Funding Information
- George Washington University (NA)
This publication has 31 references indexed in Scilit:
- Obstructive sleep apnea and endothelial progenitor cellsPatient Preference and Adherence, 2013
- Increased arterial stiffness and extracellular matrix reorganization in intrauterine growth–restricted fetal sheepPediatric Research, 2012
- Potential Role of Adult Stem Cells in Obstructive Sleep ApneaFrontiers in Neurology, 2012
- CD34+ Cells Represent Highly Functional Endothelial Progenitor Cells in Murine Bone MarrowPLOS ONE, 2011
- Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apneaVascular Health and Risk Management, 2009
- Endothelial progenitor cells: identity defined?Journal of Cellular and Molecular Medicine, 2009
- Inflammation, Oxidative Stress, and Repair Capacity of the Vascular Endothelium in Obstructive Sleep ApneaCirculation, 2008
- Vascular repair by endothelial progenitor cellsCardiovascular Research, 2008
- Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitorsExperimental Hematology, 2007
- Circulating markers of endothelial function in cardiovascular diseaseClinica Chimica Acta, 2006